Discovery Biometrics provides dedicated highly-skilled resource to meet the needs of our stakeholders.

Our mission is to deliver excellence in statistical inference and analytical expertise within Drug Discovery. This is achieved by

• Applying high quality statistical and scientific thinking to influence early drug development


• Enhancing delivery using innovative methodologies such as adaptive designs, Bayesian methods, simulation & graphics


• Partnering with our colleagues in Drug Discovery and Clinical Pharmacology to advance new medicines through Candidate Selection, First Time in Human, and "Proof of Concept".


• Timely, efficient, high-quality delivery of all Clinical Pharmacology studies

Discovery Biometrics is composed of 10 Centre of Excellence for Drug Discovery (CEDD)- aligned teams, Strategic Resourcing and Programming and Discovery Analytics.

Discovery Biometrics for CEDDs
There are 10 CEDD-specific statistics and programming teams led by CEDD-dedicated Statistics Directors. These teams have accountability for all CPDM studies from FTIH through PoC, as well as Medicines Development Centers (MDC)-funded full development Clinical Pharmacology (CP) studies.

Strategic Resourcing and Programming
The Strategic Resourcing and Programming group provides leadership for the programming efforts that support Clinical Pharmacology & Discovery Medicine (CPDM) studies and regulatory submissions, leads Discovery Biometrics resourcing strategies for statistics and programming, and provides business leadership for cross-therapeutic change activities.

Discovery Analytics
Discovery Analytics gives Drug Discovery a critical mass of scientists with a broad range of analytics expertise and experiences. Our vision is to enhance drug discovery and early clinical development by building analytics into processes and decision making.

Privacy Statement

Legal Notices